SCHEMBL22644376

SCHEMBL22644376

NC1(c2c[nH]nn2)CC(C(F)F)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL22633086 0.98
SCHEMBL22380604 0.81
Hydrochloric Acid SCHEMBL19900844 0.72
Hydrochloric Acid SCHEMBL19900958 0.72
SCHEMBL22632999 0.72
SCHEMBL19900787 0.72
Hydrochloric Acid SCHEMBL21296632 0.70
SCHEMBL22644361 0.67 APLNR (0.33)
SCHEMBL31234560 0.66
SCHEMBL2357928 0.62 ALDH1A1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200352925-A1 AMIDE DERIVATIVES USEFUL IN THE TREATMENT OF HBV INFECTION OR HBV-INDUCED DISEASES JANSSEN PHARMACEUTICA NV (BE) 2020-11-12 US disclosed
WO-2020225230-A1 AMIDE DERIVATIVES USEFUL IN THE TREATMENT OF HBV INFECTION OR HBV-INDUCED DISEASES Janssen Sciences Ireland Unlimited Company (IE) 2020-11-12 WO disclosed